These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

755 related items for PubMed ID: 19404874

  • 1. Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment.
    Dietert RR.
    J Immunotoxicol; 2008 Oct; 5(4):401-12. PubMed ID: 19404874
    [Abstract] [Full Text] [Related]

  • 2. Developmental immunotoxicity (DIT), postnatal immune dysfunction and childhood leukemia.
    Dietert RR.
    Blood Cells Mol Dis; 2009 Oct; 42(2):108-12. PubMed ID: 19019708
    [Abstract] [Full Text] [Related]

  • 3. Developmental immunotoxicology: focus on health risks.
    Dietert RR.
    Chem Res Toxicol; 2009 Jan; 22(1):17-23. PubMed ID: 18783253
    [Abstract] [Full Text] [Related]

  • 4. Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability.
    Dietert RR, Dietert JM.
    J Toxicol Environ Health B Crit Rev; 2008 Oct; 11(8):660-80. PubMed ID: 18821424
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Developmental immunotoxicity (DIT): the why, when, and how of DIT testing.
    Dietert RR, Dewitt J.
    Methods Mol Biol; 2010 Oct; 598():17-25. PubMed ID: 19967503
    [Abstract] [Full Text] [Related]

  • 8. Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer.
    Dietert RR.
    Reprod Toxicol; 2011 Apr; 31(3):319-26. PubMed ID: 20854896
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Current status of developmental immunotoxicity: early-life patterns and testing.
    DeWitt JC, Peden-Adams MM, Keil DE, Dietert RR.
    Toxicol Pathol; 2012 Apr; 40(2):230-6. PubMed ID: 22109713
    [Abstract] [Full Text] [Related]

  • 13. Testing human biologicals in animal host resistance models.
    Burleson GR, Burleson FG.
    J Immunotoxicol; 2008 Jan; 5(1):23-31. PubMed ID: 18382855
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. What's so special about the developing immune system?
    Burns-Naas LA, Hastings KL, Ladics GS, Makris SL, Parker GA, Holsapple MP.
    Int J Toxicol; 2008 Jan; 27(2):223-54. PubMed ID: 18404545
    [Abstract] [Full Text] [Related]

  • 16. Developmental immunotoxicity (DIT) in drug safety testing: matching DIT testing to adverse outcomes and childhood disease risk.
    Dietert RR.
    Curr Drug Saf; 2008 Sep; 3(3):216-26. PubMed ID: 18691005
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of dimethylbenzanthracene-induced immunotoxicity.
    Dean JH, Ward EC, Murray MJ, Lauer LD, House RV.
    Clin Physiol Biochem; 1985 Sep; 3(2-3):98-110. PubMed ID: 3924465
    [Abstract] [Full Text] [Related]

  • 18. Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.
    Collinge M, Burns-Naas LA, Chellman GJ, Kawabata TT, Komocsar WJ, Piccotti JR, Shenton J, Wierda D.
    J Immunotoxicol; 2012 Sep; 9(2):210-30. PubMed ID: 22428536
    [Abstract] [Full Text] [Related]

  • 19. Developmental immunotoxicology assessment of rituximab in cynomolgus monkeys.
    Vaidyanathan A, McKeever K, Anand B, Eppler S, Weinbauer GF, Beyer JC.
    Toxicol Sci; 2011 Jan; 119(1):116-25. PubMed ID: 20937725
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.